Acquisition History Biometics International was acquired by Pharma’s Almanac in 2010, indicating a past consolidation move and potential alignment with a larger publishing or biotech information ecosystem. This history suggests opportunities to position complementary data services, reporting, or digital marketing collaborations within a network of acquired entities.

Moderate Revenue Annual revenue is in the range of one to ten million dollars, signaling a small to midsize biotech firm with growth potential. This profile often indicates sensitivity to cost-effective solutions, scalable offerings, and clear ROI in software, lab automation, or data analytics tailored for growing teams.

Resourceful Team Size A headcount of 11–50 employees points to a lean organization where decision cycles can be quicker but budgets may be tighter. Sales opportunities could focus on high-impact, low-friction deployments, core tools that provide immediate productivity gains, and flexible pricing or pilots.

Tech Stack Gaps The listed web and UI technologies (DreamWeaver, Cufon, jQuery UI, Windows Server, IIS) suggest legacy or basic client-server infrastructure. This may indicate a need for modernization services, secure hosting, or migration to modern platforms and cloud-based lab informatics, presenting a cross-sell for upgrades.

Market Fit Potential Comparison with peers shows Biometics sits alongside smaller biometrics firms with modest revenues, presenting an opening for specialized partnerships in biometrics software, consulting, or validation services. Emphasize capabilities that address cost efficiency, regulatory readiness, and scalable data solutions to accelerate customer acquisitions in biotechnology research.